BioSpace News Archive

Press Releases

Bambusa Therapeutics Announces First Patient Dosed in Phase Ib Proof-of-Concept COPD Study of BBT002, Reinforcing Bispecific Pipeline Momentum

January 7, 2026
·
3 min read
Press Releases

Gilgamesh Pharma Announces Positive Topline Phase 2a Results for Blixeprodil (GM-1020) in Major Depressive Disorder

January 7, 2026
·
4 min read
Press Releases

Dark Blue Therapeutics acquired by Amgen for up to $840 million

January 7, 2026
·
4 min read
Press Releases

Day One Completes Acquisition of Mersana Therapeutics

January 7, 2026
·
7 min read
Press Releases

XVIVO’s CEO to present at J.P. Morgan’s 44th Annual Healthcare Conference in San Francisco

January 7, 2026
·
1 min read
Press Releases

Alpha Tau Reports New Positive Results in Two Upcoming Presentations at ASCO GI 2026 Symposium Showcasing Immune-Preservation and High Disease Control in Montreal Pancreatic Cancer Alpha DaRT® Study

January 7, 2026
·
7 min read
Press Releases

BillionToOne Announces Selection of Northstar Select® as the new liquid biopsy test for LC-SCRUM-TRY clinical study at National Cancer Center Hospital East

January 7, 2026
·
6 min read
Press Releases

YD Bio Enters into MOU to Merge with EG BioMed, Advancing DNA Methylation–Driven AI Platforms for Cancer Diagnostics and Drug Development

January 7, 2026
·
5 min read
Press Releases

The Reeve Foundation and Spinal Research Award New Grants to Advance Traumatic Spinal Cord Injury Treatments

January 7, 2026
·
7 min read
Press Releases

AMGEN ACQUIRES DARK BLUE THERAPEUTICS, BOLSTERING ONCOLOGY PIPELINE

January 7, 2026
·
8 min read